Cannara Biotech (TSXV:LOVE) Accumulated other comprehensive income (loss) : C$-0.07 Mil (As of Feb. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Cannara Biotech Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Cannara Biotech's Accumulated other comprehensive income (loss) for the quarter that ended in Feb. 2024 was C$-0.07 Mil.

Cannara Biotech's quarterly Accumulated other comprehensive income (loss) stayed the same from Aug. 2023 (C$-0.07 Mil) to Nov. 2023 (C$-0.07 Mil) and stayed the same from Nov. 2023 (C$-0.07 Mil) to Feb. 2024 (C$-0.07 Mil).

Cannara Biotech's annual Accumulated other comprehensive income (loss) declined from Aug. 2021 (C$0.10 Mil) to Aug. 2022 (C$0.02 Mil) and declined from Aug. 2022 (C$0.02 Mil) to Aug. 2023 (C$-0.07 Mil).

Cannara Biotech Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Cannara Biotech's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannara Biotech Accumulated other comprehensive income (loss) Chart

Cannara Biotech Annual Data

Trend

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Accumulated other comprehensive income (loss)

Get a 7-Day Free Trial

-0.01

0.05

0.10

0.02

-0.07

Cannara Biotech Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Accumulated other comprehensive income (loss)	Get a 7-Day Free Trial															-0.07	-0.07	-0.07	-0.07	-0.07

Cannara Biotech Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Cannara Biotech Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Cannara Biotech's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Cannara Biotech (TSXV:LOVE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannara Biotech Inc (TSXV:LOVE) » Definitions » Accumulated other comprehensive income (loss)

Comparable Companies

Traded in Other Exchanges

LOVFF:USA 8CB0:Germany

Address

1055 West Georgia Street, Suite 2050, Vancouver, BC, CAN, V6E 3P3

Website

http://www.cannara.ca

Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for Canadian markets. The company owns two mega Quebec-based facilities. The company operates in in two segments; Indoor cannabis operations segment which includes the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and the Real estate operations segment related to the Farnham and Valleyfield building. Majority of the revenue for the company is generated from its Cannabis operations segment. .